Lonza Reaffirms Commitment to Teva Biosimilars JV in Light of 'Inaccurate' Reports
Lonza has reiterated its commitment to its biosimilars JV with Teva after various news stories hinted the future of the partnership was in doubt.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs